Andrew Guggenhime
CFO, President at Vaxcyte, Inc. (PCVX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 5SEC | PCVXVaxcyte, Inc. | Sell Plan | 6,956108,220 held (−6%) | $53.76 | $374K | +32.8% |
| Aug 5SEC | PCVXVaxcyte, Inc. | Sell Plan | 3,044105,176 held (−3%) | $54.18 | $165K | +31.7% |
| Jul 6SEC | PCVXVaxcyte, Inc. | Sell Plan | 7,913106,482 held (−7%) | $57.16 | $452K | +24.9% |
| Jul 6SEC | PCVXVaxcyte, Inc. | Sell Plan | 2,087104,395 held (−2%) | $57.76 | $121K | +23.6% |
| Jun 18SEC | PCVXVaxcyte, Inc. | Sell Plan | 10,000104,395 held (−9%) | $53.00 | $530K | +34.7% |
- Sell
CFO, President Andrew Guggenhime sold $374K of PCVX at $53.76 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Andrew Guggenhime sold $165K of PCVX at $54.18 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Andrew Guggenhime sold $452K of PCVX at $57.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Andrew Guggenhime sold $121K of PCVX at $57.76 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Andrew Guggenhime sold $530K of PCVX at $53.00 — pre-scheduled 10b5-1 plan sale.